1092447-20-5

Basic information

• Product Name: 2-(2-cyclopropylmethoxy-3-methyl-benzoylamino)-indan-2-carboxylic acid ethyl ester
• Synonyms: 2-(2-cyclopropylmethoxy-3-methyl-benzoylamino)-indan-2-carboxylic acid ethyl ester
• CAS NO: 1092447-20-5
• Molecular Weight: 393.483
• Mol File: 1092447-20-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(2-cyclopropylmethoxy-3-methyl-benzoylamino)-indan-2-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-cyclopropylmethoxy-3-methyl-benzoylamino)-indan-2-carboxylic acid ethyl ester(1092447-20-5)
• EPA Substance Registry System: 2-(2-cyclopropylmethoxy-3-methyl-benzoylamino)-indan-2-carboxylic acid ethyl ester(1092447-20-5)

Safety Data

• Hazardous Substances Data: 1092447-20-5(Hazardous Substances Data)

Upstream product

• 1092447-16-9 2-(2-hydroxy-3-methyl-benzoylamino)-indan-2-carboxylic acid ethyl ester 
• 7051-34-5 cyclopropylcarbinyl bromide 
• 141104-65-6 ethyl 2-amino-2,3-dihydro-1H-indene-2-carboxylate 

Downstream Products

• 1092445-36-7 2-(2-cyclopropylmethoxy-3-methylbenzoylamino)indan-2-carboxylic acid 

Relevant articles and documents

SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS

The present invention relates to A compound of the formula Ia wherein in any of its stereoisomers forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.